Clark Estates’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.79M Buy
+278,000
New +$2.57M 0.65% 34

Other funds holding ADMA

Clark Estates's ADMA Position: Q3 2026 in Review

Clark Estates opened a new position in ADMA Biologics (ADMA) in Q3 2026: 278,000 shares worth $2.79M. The stake represents 0.65% of the portfolio and ranks #34 among its holdings.

262 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • Clark Estates held 278,000 shares of ADMA Biologics worth $2.79M as of Q3 2026.
  • ADMA Biologics was a new Clark Estates position in Q3 2026.
  • ADMA Biologics made up 0.65% of Clark Estates's portfolio in Q3 2026, its #34 holding.
  • 262 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Clark Estates's 13F filing for Q3 2026, filed 10 Nov 2026.